Xiaojun Shi

1.2k citations
40 papers · 947 indexed · h-index 16
Topics
Bladder and Urothelial Cancer Treatments (5 papers)Skin Protection and Aging (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)
Journals
SHILAP Revista de lepidopterologíaNano LettersBritish Journal of Pharmacology
Partner nations
ChinaCanadaUnited States

In The Last Decade

Xiaojun Shi

37 papers receiving 936 citations

Peers

Xiaojun Shi
Comparison fields: 5 of 106
  • Molecular Biology 297
  • Biomaterials 170
  • Biomedical Engineering 118
  • Pharmaceutical Science 115
  • Dermatology 114
Replace Yuxin Jiang with:
Yuxin Jiang China
Manuela Carvalheiro Portugal
Octavio D. Reyes‐Hernández Mexico
Maria Perde‐Schrepler Romania
Saurav Kumar Jha India
Soheil Abbaspour‐Ravasjani Iran
Ting Zhong China
Ekram Alias Malaysia
Xiaojun Shi relative to Yuxin Jiang China Yuxin Jiang's profile →
Citations per field
00.5×3.7×
Yuxin Jiang · 1×
Citations per year

Countries citing papers authored by Xiaojun Shi

Since Specialization
Citations

This map shows the geographic impact of Xiaojun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Shi more than expected).

Fields of papers citing papers by Xiaojun Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Shi. The network helps show where Xiaojun Shi may publish in the future.

Co-authorship network of co-authors of Xiaojun Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Shi. A scholar is included among the top collaborators of Xiaojun Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Shi. Xiaojun Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 12
4 0
5 8
6 9
7 9
8 7
9 2
10 4
11 21
12 7
13 8
14 151
15 4
16 63
17 36
18 116
19 29
20 19

About Xiaojun Shi

Xiaojun Shi is a scholar working on Dermatology, Hepatology and Gastroenterology, having authored 40 papers that have together received 947 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Skin Protection and Aging (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Pharmaceutical Science (115 citations), Biochemistry (78 citations) and Biomaterials (170 citations). Xiaojun Shi has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Houjie Chen, Li Ding, Xianbing Zhu, Dawei Chen, Sheng‐Tao Hou, Haiyang Hu, Yong‐yuan Zhu, Zhi‐Xiu Lin, Wei Tao and Xiang Ling. Their work appears in journals such as SHILAP Revista de lepidopterología, Nano Letters and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026